HEALTH CATALYST INC

Health Catalyst CEO buys nearly 2.8 million shares, signaling strong confidence in the company’s AI‑driven health‑tech future.

Health Catalyst CEO sells 35,244 shares to cover RSU vesting—routine move that keeps liquidity stable and signals confidence in the company’s long‑term strategy.

Health Catalyst insiders reveal CEO Albert Benjamin’s performance‑based PRSU award—showing leadership confidence and a bullish outlook for 2026 earnings.

Health Catalyst CEO’s recent sell‑to‑cover of 70,455 shares: why the move is routine, what it signals about insider confidence, and how to interpret the stock’s steep slide.

Health Catalyst’s CEO buys 930,000 RSUs and 38,833 PRSUs amid a 63 % yearly dip, signaling executive confidence and a strategy to drive future revenue growth.

Health Catalyst’s insider buying shows confidence amid low prices, suggesting a possible rebound if the company expands its data‑analytics platform beyond Utah.